SGRY (Surgery Partners) Additional Paid-In Capital : $2,521 Mil(As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Surgery Partners Additional Paid-In Capital?

Surgery Partners's quarterly additional paid-in capital increased from Jun. 2024 ($2,511 Mil) to Sep. 2024 ($2,514 Mil) and increased from Sep. 2024 ($2,514 Mil) to Dec. 2024 ($2,521 Mil).

Surgery Partners's annual additional paid-in capital increased from Dec. 2022 ($2,478 Mil) to Dec. 2023 ($2,498 Mil) and increased from Dec. 2023 ($2,498 Mil) to Dec. 2024 ($2,521 Mil).

Surgery Partners Additional Paid-In Capital Historical Data

The historical data trend for Surgery Partners's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgery Partners Additional Paid-In Capital Chart

Surgery Partners Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

607.90

1,622.30

2,478.00

2,497.60

2,520.90

Surgery Partners Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Additional Paid-In Capital	Get a 7-Day Free Trial															2,497.60	2,495.60	2,511.10	2,513.50	2,520.90

Surgery Partners Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

Surgery Partners Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Surgery Partners's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgery Partners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Surgery Partners Inc (NAS:SGRY) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

1SP:Germany

Address

340 Seven Springs Way, Suite 600, Brentwood, TN, USA, 37027

Website

https://www.surgerypartners.com

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

Executives

Danielle Burkhalter	officer: Chief Human Resources Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Jennifer Baldock	officer: Sr. VP, Gen Couns. & Sec.	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Harrison R. Bane	officer: American Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Marissa Brittenham	officer: Chief Strategy Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
David T Doherty	officer: Chief Financial Officer	310 SEVEN SPRINGS WAY, BRENTWOOD TN 37027
Jason Eric Evans	officer: EVP & Chief Operating Officer	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Bradley R. Owens	officer: National Group President	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Anthony Taparo	officer: President, Atlantic Group	310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD TN 37027
Bain Capital Investors Llc	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
T. Devin O'reilly	director, 10 percent owner	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02149
Blair E Hendrix	director, 10 percent owner
Andrew T. Kaplan	director	C/O BAIN CAPITAL PRIVATE EQUITY, LP, 200 CLARENDON STREET, BOSTON MA 02116
Wayne S Deveydt	director, officer: Chief Executive Officer	120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Bain Capital Partners Xi, L.p.	director, 10 percent owner	200 CLARENDON STREET, BOSTON MA 02116
Bain Capital Fund Xi, L.p.	director, 10 percent owner	JOHN HANCOCK TOWER, 200 CLARENDON STREET, BOSTON MA 02116